Aminoglycoside induced ototoxicity risk in the cystic fibrosis population: The utility of large‐scale screening
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.26259
Abstract: MT‐RNR1 variants are a well‐known cause of aminoglycoside‐induced hearing loss (AIHL). Individuals with cystic fibrosis (CF) routinely receive aminoglycosides and are at high risk of AIHL. However, genetic testing before treatment is not routinely performed… read more here.
Keywords: ototoxicity risk; risk; aminoglycoside induced; cystic fibrosis ... See more keywords